Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
12.19
+0.10 (0.83%)
At close: Nov 4, 2024, 4:00 PM
12.71
+0.52 (4.27%)
After-hours: Nov 4, 2024, 7:59 PM EST
Perspective Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2022 | FY 2021 | FY 2020 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Net Income | -59.02 | -46.51 | -10.76 | -7.27 | -3.39 | -3.45 | |
Depreciation & Amortization | 1.45 | 0.98 | 0.32 | 0.28 | 0.21 | 0.21 | |
Other Amortization | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Loss (Gain) From Sale of Assets | - | 0.02 | 0.31 | - | 0.01 | - | |
Loss (Gain) on Equity Investments | 0.02 | 0.02 | - | - | - | - | |
Stock-Based Compensation | 2.92 | 3.74 | 0.98 | 1.09 | 0.39 | 0.5 | |
Provision & Write-off of Bad Debts | 0.58 | 0.62 | - | - | - | - | |
Other Operating Activities | 11.88 | 1.88 | -0.22 | 0 | 0 | -0.07 | |
Change in Accounts Receivable | 0.35 | -0.43 | 0.28 | 0.41 | 0.03 | -0.89 | |
Change in Inventory | 0.36 | 0.36 | -2 | -2.67 | -0.27 | -0.1 | |
Change in Accounts Payable | 0.38 | 1.58 | 0.69 | 0.24 | 0.08 | -0.03 | |
Change in Other Net Operating Assets | -0.62 | 0.78 | -0.03 | 0.18 | 0.1 | 0.18 | |
Operating Cash Flow | -14.17 | -36.91 | -10.4 | -7.71 | -2.84 | -3.64 | |
Capital Expenditures | -10.4 | -1.07 | -0.28 | -0.27 | -0.38 | -0.27 | |
Sale of Property, Plant & Equipment | - | - | - | - | 0 | - | |
Cash Acquisitions | - | 2.7 | - | - | - | - | |
Investment in Securities | -40.51 | 22.76 | -22.69 | - | - | - | |
Other Investing Activities | - | -0.02 | -6.02 | -0.02 | -0.03 | -0.01 | |
Investing Cash Flow | -50.91 | 24.37 | -28.99 | -0.28 | -0.41 | -0.29 | |
Long-Term Debt Repaid | - | -0.07 | - | - | - | - | |
Net Debt Issued (Repaid) | -0.05 | -0.07 | - | - | - | - | |
Issuance of Common Stock | 288.45 | 0.55 | 0.03 | 0.06 | 64.69 | 1.01 | |
Preferred Dividends Paid | - | - | - | - | -0.01 | -0.01 | |
Dividends Paid | - | - | - | - | -0.01 | -0.01 | |
Other Financing Activities | 0.36 | 0.3 | - | - | - | - | |
Financing Cash Flow | 288.77 | 0.79 | 0.03 | 0.06 | 64.68 | 0.99 | |
Net Cash Flow | 223.69 | -11.76 | -39.36 | -7.94 | 61.44 | -2.93 | |
Free Cash Flow | -24.58 | -37.99 | -10.68 | -7.98 | -3.22 | -3.91 | |
Free Cash Flow Margin | -1678.62% | -2648.88% | -197.29% | - | -32.01% | -40.43% | |
Free Cash Flow Per Share | -0.57 | -1.42 | -0.75 | -0.56 | -0.31 | -0.58 | |
Cash Interest Paid | 0.08 | 0.08 | - | - | - | - | |
Levered Free Cash Flow | -33.29 | -8.27 | - | -2.73 | -2.08 | -2.64 | |
Unlevered Free Cash Flow | -33.23 | -8.22 | - | -2.73 | -2.08 | -2.64 | |
Change in Net Working Capital | -3.85 | -14.31 | - | -0.48 | 0.15 | 0.91 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.